| Publisher: AACR
| ||||||||
|
Clinical Cancer Research
Journal Prestige (SJR): 4.929  Citation Impact (citeScore): 8 Number of Followers: 49  Hybrid journal (It can contain Open Access articles)ISSN (Print) 1078-0432 - ISSN (Online) 1557-3265 Published by AACR  [3 journals]
|
- 694146">
Selected Articles from This Issue
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694166"> In an Era of ctDNA, Is Metabolomics the New Kid on the
Block'-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694152"> Microenvironment Is a Key Determinant of Immune Checkpoint
Inhibitor Response-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694149"> FDA Approval Summary: Sotorasib for KRAS G12C-Mutated
Metastatic NSCLC-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694154"> FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced
or Metastatic HER2-Positive Breast Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694163"> Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients
with Advanced Triple-Negative Breast Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694171"> Clinical Significance of PIK3CA and ESR1 Mutations in Circulating
Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus
Fulvestrant-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694169"> Phase Ib Trial of the Combination of Imatinib and Binimetinib in
Patients with Advanced Gastrointestinal Stromal Tumors-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694173"> Tumor Genomic Testing for >4,000 Men with Metastatic
Castration-resistant Prostate Cancer in the Phase III Trial PROfound
(Olaparib)-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694159"> A Phase Ib/II Study of the CDK4/6 Inhibitor Ribociclib in
Combination with Docetaxel plus Prednisone in Metastatic
Castration-Resistant Prostate Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694145"> Telaglenastat Plus Cabozantinib or Everolimus for Advanced or
Metastatic Renal Cell Carcinoma: An Open-Label Phase I Trial-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694148"> Phase I/II Trial of Enzalutamide and Mifepristone, a
Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant
Prostate Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694151"> Afatinib and Pembrolizumab for Recurrent or Metastatic Head and
Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with
Biomarker Analysis-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694153"> Convection Enhanced Delivery of the Oncolytic Adenovirus
Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial
Including Correlative Studies-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694158"> A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or
Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in
Advanced Sarcoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694162"> Tumor Drug Concentration and Phosphoproteomic Profiles After Two
Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed
Glioblastoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694165"> Exposure-Response Analysis to Support Nivolumab Once Every 4
Weeks Dosing in Combination with Cabozantinib in Renal Cell Carcinoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694144"> Bone Marrow Surveillance of Pediatric Cancer Survivors Identifies
Clones that Predict Therapy-Related Leukemia-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694168"> Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy
Using C-X-C Chemokine Receptor Type 4 Radioligands-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694170"> Comparative Analysis and Isoform-Specific Therapeutic
Vulnerabilities of KRAS Mutations in Non-Small Cell Lung Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694157"> Metabolomic Biomarkers in Blood Samples Identify Cancers in a
Mixed Population of Patients with Nonspecific Symptoms-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694147"> ESMO Scale for Clinical Actionability of Molecular Targets
Driving Targeted Treatment in Patients with Cholangiocarcinoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694164"> Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT
Mutations: Results from a Multi-institutional European Retrospective Study
-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694150"> Transcriptomic Determinants of Response to Pembrolizumab
Monotherapy across Solid Tumor Types-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694172"> Tumor Immunogenomic Features Determine Outcomes in Patients with
Metastatic Colorectal Cancer Treated with Standard-of-Care Combinations of
Bevacizumab and Cetuximab-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694143"> Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma,
Dominated by Myeloid and B Cells-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694142"> Post-transplant Malignancies Show Reduced T-cell Abundance and
Tertiary Lymphoid Structures as Correlates of Impaired Cancer
Immunosurveillance-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694167"> Integrated Analysis of Ovarian Juvenile Granulosa Cell Tumors
Reveals Distinct Epigenetic Signatures and Recurrent TERT Rearrangements-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694156"> Correction: First-in-Class Anti-Immunoglobulin-like Transcript 4
Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in
Patients with Advanced Solid Tumors-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694155"> Correction: Pilot Phase II Trial of Neoadjuvant Immunotherapy in
Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of
the Head and Neck-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694177"> Correction: Alternative Splicing of EZH2 pre-mRNA by SF3B3
Contributes to the Tumorigenic Potential of Renal Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694176"> Correction: Absence of Cytomegalovirus in Glioblastoma and Other
High-grade Gliomas by Real-time PCR, Immunohistochemistry, and In Situ
Hybridization-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694161"> Correction: BATF2 Deficiency Promotes Progression in Human
Colorectal Cancer via Activation of HGF/MET Signaling: A Potential
Rationale for Combining MET Inhibitors with IFNs-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694175"> Correction: Detection of miR-34a Promoter Methylation in
Combination with Elevated Expression of c-Met and β-Catenin Predicts
Distant Metastasis of Colon Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694174"> Correction: Sphingosine Kinase-1 Enhances Resistance to Apoptosis
through Activation of PI3K/Akt/NFκB Pathway in Human Non-small Cell Lung
Cancer-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
- 694160"> Editor's Note: Fibroblast Growth Factor Receptor 2-Positive
Fibroblasts Provide a Suitable Microenvironment for Tumor Development and
Progression in Esophageal Carcinoma-
Free pre-print version: Loading...Rate this result: What is this?Please help us test our new pre-print finding feature by giving the pre-print link a rating.
A 5 star rating indicates the linked pre-print has the exact same content as the published article.
PubDate: 2022-04-18T23:20:50-05:00
Issue No: Vol. 28, No. 8 (2022)
-
